Follicular lymphoma, unspecified, lymph nodes of multiple sites
ICD-10 C82.98 is a billable code used to indicate a diagnosis of follicular lymphoma, unspecified, lymph nodes of multiple sites.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is typically indolent but can transform into a more aggressive form. The unspecified designation indicates that the specific characteristics of the lymphoma are not detailed, which can complicate treatment and prognosis. This lymphoma often presents in the lymph nodes, and when it involves multiple sites, it indicates a more systemic disease. Patients may experience B-symptoms, which include fever, night sweats, and weight loss. Diagnosis is usually confirmed through biopsy and imaging studies. Staging is crucial, as it determines the extent of the disease and guides treatment options, which may include watchful waiting, chemotherapy, immunotherapy, or stem cell transplant depending on the stage and patient health. The prognosis varies widely based on these factors.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis confirmation through biopsy, treatment planning for chemotherapy or immunotherapy.
Ensure all relevant symptoms and staging details are documented to support coding.
Imaging reports detailing lymph node involvement and any changes over time.
Imaging studies used to assess the extent of lymphoma spread.
Radiology reports should clearly indicate the number and location of affected lymph nodes.
Used to monitor blood counts during treatment.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure that all relevant lab results are included.
Common treatments include watchful waiting for early-stage disease, chemotherapy, immunotherapy, and in some cases, stem cell transplant for advanced disease.
